Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 24, 2018
Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone in the Treatment of Friedreich’s Ataxia and Other Severe Neurological Diseases
IRVING, Texas, April 24, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating ...
April 24, 2018
DURECT Corporation Invites You to Join its First Quarter 2018 Earnings Conference Call
CUPERTINO, Calif., April 24, 2018 /PRNewswire/ -- In conjunction with DURECT Corporation's(DRRX) first quarter 2018 financial results press release, you are invited to listen to a ...
April 24, 2018
OSE Immunotherapeutics Receives the EuroNext Tech40 Label
NANTES, France, April 23, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE) has received the EuroNext Tech40 Label and is thus admitted to the “Tech40” ...
April 24, 2018
Biom’up Has Trained 200 Surgeons in its International KOL-Led Program Ahead of HEMOBLAST Bellows™ Launch
NEW YORK and SAINT-PRIEST, France, April 24, 2018 (GLOBE NEWSWIRE) -- Biom'up (BUP.PA), a specialist in surgical hemostasis, today announced that its intensive training program ...
April 24, 2018
Lysogene Signs Partnership Agreement with Dr. Hervé Moine, Researcher at the IGBMC(1) and the SATT(2) Conectus Alsace, in the Fragile X Syndrome
CAMBRIDGE, Mass. and PARIS, April 24, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central ...
April 24, 2018
PureTech Health Appoints Joep Muijrers as Chief Financial Officer
BOSTON--(BUSINESS WIRE)--PureTech Health plc (PRTC.L) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, is pleased to announce today the appointment of Joep Muijrers, ...
April 24, 2018
Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2018
SAN DIEGO and TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
April 24, 2018
Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting
JERUSALEM, April 24, 2018 /PRNewswire/ -- Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces that data collected from two Phase 1 studies ...
April 24, 2018
CytoSorbents Enrolls First Patient into Pivotal U.S. REFRESH 2-AKI Trial Using CytoSorb® During Complex Cardiac Surgery
MONMOUTH JUNCTION, N.J., April 24, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation ...
April 24, 2018
ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership
RAMSEY, N.J. and BOCA RATON, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), today announced that it has ...
April 24, 2018
ESSA Pharma Enhances R&D Capabilities with Two New Key Hires
HOUSTON and VANCOUVER , April 24, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on ...
April 24, 2018
PolarityTE Announces Appointment of McKesson’s Willie Bogan to Board of Directors
SALT LAKE CITY, April 24, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of ...
April 20, 2018
Theravance Biopharma Highlights Landmark IMPACT Study Published in NEJM Showing Significant Benefits of Trelegy Ellipta for COPD Patients
DUBLIN, April 19, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma") today highlighted the publication in the New England Journal of Medicine (NEJM) of the ...
April 20, 2018
ESSA Pharma Inc. Announces Share Consolidation
HOUSTON and VANCOUVER , April 19, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company ...
April 20, 2018
Basilea reports presentations of isavuconazole and ceftobiprole data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Basel, Switzerland, April 20, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today that a broad range of posters and presentations on the antifungal isavuconazole (Cresemba®) ...
April 20, 2018
Arcturus Therapeutics Files Lawsuit Against Joseph E. Payne and His Associates for Violations of Federal Securities Laws
SAN DIEGO, April 20, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, initiated a lawsuit in the United States District Court for ...
April 19, 2018
Pfenex and NT Pharma Enter into a Development and License Agreement for Pfenex's PF708 Therapeutic Equivalent Candidate to Forteo®
SAN DIEGO and HONG KONG, April 18, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE AMERICAN: PFNX) and China NT Pharma Group Company Limited (NT Pharma) (1011.HK) today ...
April 19, 2018
Aeglea BioTherapeutics Prices Public Offering of Common Stock
AUSTIN, Texas, April 18, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
April 19, 2018
Management Change in Moberg Pharma
STOCKHOLM, April 19th, 2018 /PRNewswire/ --Moberg Pharma AB (OMX:MOB) announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with ...
April 19, 2018
iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37
NASHUA, N.H. and BARCELONA, Spain, April 19, 2018 (GLOBE NEWSWIRE) -- ESTRO Booth 6800 -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative ...
Page 81 of 150